Delivery Order SPE2DP20D0002-SPE2DP24F2823
- Not listed
- This is a firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Teva Pharmaceuticals USA, Inc., a foreign-owned, for-profit pharmaceutical manufacturer. The contract has a ceiling value of $635,218.92 and a period of performance ending on November 19, 2024. The award is for the delivery of Adenovirus Type 4 vaccine, which supports military immunization programs. Teva Pharmaceuticals USA, Inc. is a major pharmaceutical supplier to federal agencies,...
- The Defense Logistics Agency Troop Support Medical awarded a Firm Fixed Price delivery order to Teva Pharmaceuticals USA, Inc., a foreign-owned, for-profit manufacturer, to provide Adenovirus Type 4 vaccine. The $135,747.00 award has an October 27, 2020 completion date and was issued on October 19, 2020. This delivery order supports military immunization programs. Teva Pharmaceuticals USA, Inc. holds multiple indefinite delivery contracts with federal agencies, including a 5-year IDIQ with the...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency Troop Support Medical to Teva Pharmaceuticals USA, Inc., a foreign-owned, for-profit pharmaceutical manufacturer, to provide Adenovirus Type 4 vaccine. The $423,530.64 order was placed on August 11, 2021, with a completion date of August 24, 2021. Teva has provided various drug products, including vaccines, antivirals, and respiratory treatments, to federal customers such as the Department of Defense and Department...
- The U.S. Defense Logistics Agency Troop Support Medical awarded a $146,823.93 firm fixed price delivery order to Teva Pharmaceuticals USA, Inc., a pharmaceutical manufacturer, to provide adenovirus type 4 vaccine. This order supports military immunization programs. Teva Pharmaceuticals USA, Inc. is a foreign-owned, for-profit organization that manufactures a range of drug products, including vaccines, antivirals, respiratory treatments, and multiple sclerosis medications for federal customers...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Teva Pharmaceuticals USA, Inc., a foreign-owned, for-profit pharmaceutical manufacturer. The contract, valued at $635,218.92, is for the delivery of Adenovirus Type 4 vaccine, which supports military immunization programs. The contract is a firm-fixed-price delivery order with a period of performance through November 19, 2024. Teva Pharmaceuticals USA, Inc. is a major supplier of critical...
- The Defense Logistics Agency Troop Support Medical awarded a firm-fixed-price delivery order to Teva Pharmaceuticals USA, Inc., a foreign-owned for-profit pharmaceutical manufacturer, to provide Adenovirus Type 4 vaccine. The $135,747 order has an October 27, 2020 completion date and was awarded on October 19, 2020. Teva Pharmaceuticals USA, Inc. has provided various drug products, including vaccines, to federal agencies such as the Department of Defense and Department of Veterans Affairs. While...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm-fixed-price delivery order to Teva Pharmaceuticals USA, Inc., a pharmaceutical manufacturer, to provide Adenovirus Type 4 vaccine. The $282,353.76 contract has an April 27, 2021 completion date and does not have a set-aside designation. Teva Pharmaceuticals USA, Inc. is a foreign-owned, for-profit organization that has supplied various pharmaceutical products, including vaccines, antiviral medications, respiratory...
- The Defense Logistics Agency (DLA) Troop Support Medical awarded a $317,609.46 firm-fixed-price delivery order to Teva Pharmaceuticals USA, Inc., a foreign-owned, for-profit pharmaceutical manufacturer, to provide Adenovirus Type 4 vaccine. This delivery order has a completion date of January 30, 2024. Teva Pharmaceuticals USA, Inc. is the prime contractor and there is no set-aside designation for this award. The company has previously fulfilled multiple federal contracts and...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Teva Pharmaceuticals USA, Inc., a pharmaceutical manufacturer, for the supply of Adenovirus Type 4 vaccine. The firm-fixed-price contract has a potential value of $135,747.00 and a completion date of November 17, 2020. The award was made on November 3, 2020, and there was no set-aside designation. Teva Pharmaceuticals USA, Inc. is a foreign-owned, for-profit organization that has provided various...
- This delivery order was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Teva Pharmaceuticals USA, Inc., a foreign-owned, for-profit pharmaceutical manufacturer. The contract is for the delivery of Adenovirus Type 4 vaccine, valued at $423,530.64, to be completed by November 16, 2021. The contract is a firm-fixed price delivery order and does not have a set-aside designation. Teva Pharmaceuticals USA, Inc. has previously received numerous delivery orders from DLA to...
- SPE2DP20D0002Indefinite Delivery Contract
- SPE2DP20D0002-SPE2DP24F2823Delivery Order
This is a firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Teva Pharmaceuticals USA, Inc., a foreign-owned, for-profit pharmaceutical manufacturer. The $635,218.92 order is for the delivery of Adenovirus Type 4 vaccine, which supports military immunization programs. The order has a completion date of February 27, 2024 and was awarded on February 22, 2024. This award is not associated with a set-aside designation. Teva Pharmaceuticals USA, Inc. has been awarded numerous prime contracts and delivery orders from federal agencies like the Department of Veterans Affairs (VA), Department of Defense (DOD), and Bureau of Prisons to supply critical pharmaceutical products, including vaccines, antiviral medications, and respiratory treatments.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $635.2k | 2/22/24 |